Ulcerated lesions on upper and lower limbs of 5 years of evolution

Authors

  • Fabiana Paola del Valle Argañaraz Hospital de Clínicas Pte. Dr. Nicolás Avellaneda, Tucumán, Argentina
  • Adriana Beatriz Liatto de Nogalo Hospital de Clínicas Pte. Dr. Nicolás Avellaneda, Tucumán, Argentina
  • Silvana Aidé López Hospital de Clínicas Pte. Dr. Nicolás Avellaneda, Tucumán, Argentina
  • Silvia Graciela Molina Hospital de Clínicas Pte. Dr. Nicolás Avellaneda, Tucumán, Argentina

DOI:

https://doi.org/10.47196/da.v31i3.2974

Keywords:

ulcerated lesions, upper limbs, lower limbs

Abstract

A 49-year-old male patient from the province of Tucumán reported a history of multiple hospitalizations, with voluntary discharge each time, due to painful ulcerated lesions on his elbows and legs that had been present for 5 years and were associated with abdominal pain and fatigue. Physical examination revealed pale skin and mucous membranes, thinning skin, absence of eyelashes and eyebrows, bilateral cataracts, and a saddle nose. On his elbows and legs, he presented ulcers of varying sizes that were exudative, malodorous, and some were bleeding, with abundant fibrin and scant granulation tissue.

Author Biographies

Fabiana Paola del Valle Argañaraz, Hospital de Clínicas Pte. Dr. Nicolás Avellaneda, Tucumán, Argentina

4th year Dermatology Resident

Adriana Beatriz Liatto de Nogalo, Hospital de Clínicas Pte. Dr. Nicolás Avellaneda, Tucumán, Argentina

Staff Physician, Dermatology Service, Deputy Director of the Dermatology Residency

Silvana Aidé López, Hospital de Clínicas Pte. Dr. Nicolás Avellaneda, Tucumán, Argentina

Staff Physician, Dermatology Department, Dermatology Residency Instructor

Silvia Graciela Molina, Hospital de Clínicas Pte. Dr. Nicolás Avellaneda, Tucumán, Argentina

Staff Physician, Dermatology Service, Director of the Dermatology Residency Program

References

I. Medina C, Roses M, Pereyra SB, Recarte M, et ál. Edición especial. Lepra. Tratamiento. Educándonos. 2018;4:8-51.

II. Vidal-Cobo JM, Mojena-Parada L, Zayas-Pouyort A, Fournier-Cartaya M. Aspectos clínico epidemiológicos de la enfermedad de Hansen en un área de salud. Folia Dermatológica Cubana. 2021;15:1-9.

III. Blanco-Córdova CA, Claxton-Louit M. Lepra lepromatosa. Presentación de un caso. Medisur. 2018;16:593-598.

IV. Nájera-Gómez J, Tolentino-Masgo W, Gómez-Hinojosa P, Figueroa-Gamarra L. Lepra lepromatosa. Rev Peru Invest Salud. 2017;1:58-65.

V. Organización Mundial de la Salud. Hacia cero lepra. Estrategia mundial contra la lepra (enfermedad de Hansen) 2021-2030. India; 2021. Disponible en: file:///C:/Users/usuario/Downloads/9789290228417spa%20(3).pdf. [consultado marzo 2024].

VI. Jaled M, Soto I, Medina MC, Tiscornia J, et ál. Consenso sobre prevención, diagnóstico y tratamiento de la lepra. Salta; 2018. Ministerio de Salud. Disponible en: http://saladesituacion.salta.gov.ar/php/documentos/edis/manual_de_procedimientos_de_Lepra_20182.pdf.

VII. Organización Mundial de la Salud. Lepra (mal de Hansen). 2023. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/leprosy [consultado octubre 2024].

VIII. Sabha Mushtaq. Ulcerative type 1 lepra reaction in borderline-tuberculoid leprosy: a rare presentation. Hansen Int. 2024;49:1-8.

Published

2025-12-01

Issue

Section

What is your Diagnosis?